###begin article-title 0
Antagonistic action of Six3 and Prox1 at the gamma-crystallin promoter
###end article-title 0
###begin p 1
###xml 97 108 97 108 <email xmlns:xlink="http://www.w3.org/1999/xlink">graw@gsf.de</email>
To whom correspondence should be addressed. Tel: +49 89 3187 2610; Fax: +49 89 3187 2210; Email: graw@gsf.de Present address: Eberhard Krausz, Cyclacel Ltd, Dundee, UK
###end p 1
###begin p 2
###xml 178 183 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 184 185 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 393 398 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 399 400 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 401 402 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 580 585 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 638 643 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 644 645 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 719 724 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 775 780 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PROX1</italic>
###xml 820 825 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 914 918 910 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 943 947 939 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 1027 1032 1023 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 1033 1034 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1035 1036 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 1320 1325 1312 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 1326 1327 1318 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1328 1329 1320 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 171 177 <span type="species:ncbi:10090">murine</span>
gamma-Crystallin genes are specifically expressed in the eye lens. Their promoters constitute excellent models to analyse tissue-specific gene expression. We investigated murine Cryge/f promoters of different length in lens epithelial cell lines. The most active fragment extends from position -219 to +37. Computer analysis predicts homeodomain and paired-domain binding sites for all rodent Crygd/e/f core promoters. As examples, we analysed the effects of Prox1 and Six3, which are considered important transcription factors involved in lens development. Because of endogenous Prox1 expression in N/N1003A cells, a weak stimulation of Cryge/f promoter activity was found for PROX1. In contrast, PROX1 stimulated the Crygf promoter 10-fold in CD5A cells without endogenous PROX1. In both cell lines Six3 repressed the Crygf promoter to 10% of its basal activity. Our cell transfection experiments indicated that Cryg expression increases as Six3 expression decreases. Prox1 and Six3 act antagonistically on regulation of the Crygd/e/f promoters. Functional assays using randomly mutated gammaF-crystallin promoter fragments define a Six3-responsive element between -101 and -123 and a Prox1-responsive element between -151 and -174. Since Prox1 and Six3 are present at the beginning of lens development, expression of Crygd/e/f is predicted to remain low at this time. It increases as Six3 expression decreases during ongoing lens development.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 225 230 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryga</italic>
###xml 231 236 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 254 255 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c1">1</xref>
###xml 256 257 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c2">2</xref>
###xml 278 282 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 430 431 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c3">3</xref>
###xml 432 433 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c4">4</xref>
###xml 453 457 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 597 598 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c5">5</xref>
###xml 599 600 591 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c8">8</xref>
###xml 267 272 <span type="species:ncbi:10090">mouse</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
###xml 497 500 <span type="species:ncbi:9606">man</span>
The gamma-crystallins are recognised as structural proteins, expressed specifically in the eye lens of mammals and other vertebrates (with the exception of birds). The gamma-crystallins are encoded by a cluster of six genes, Cryga-Crygf (for reviews see 1,2). In the mouse, the Cryg genes are expressed from embryonic day (E) 13.5 onwards in primary fibre cells and later on in secondary fibre cells, but not in epithelial cells (3,4). Mutations in the Cryg genes have been reported for mouse and man and it is commonly accepted that these mutations are causative for a variety of lens opacities (5-8).
###end p 4
###begin p 5
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 209 210 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f1">1</xref>
###xml 181 184 <span type="species:ncbi:10116">rat</span>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
 Because of the unique expression in the lens, the regulation of Cryg gene expression has been studied in various laboratories. The highly conserved proximal promoter region in the rat Cryge/f and mouse Crygd/e/f genes is characterised by binding sites for transcription factors and by a variety of sequence elements with remarkable features but without known functions (Fig. 1).
###end p 5
###begin p 6
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c18">18</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c26">26</xref>
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
###xml 240 255 <span type="species:ncbi:10090">transgenic mice</span>
 Additionally, there are differences in the response of cell culture systems and transgenic mice using the same promoter region. For example, the fragment -67/+45 of the proximal Crygf promoter is sufficient for lens-specific expression in transgenic mice (18). However, in N/N1003A lens cells the smallest promoter eliciting activity is the -226/+45 fragment (26).
###end p 6
###begin p 7
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c27">27</xref>
 On the other hand, a broad variety of transcription factors have been demonstrated to be involved in proper regulation of lens development and differentiation (27). However, only a few of them have been investigated with respect to their function in the regulation of gamma-crystallin encoding genes.
###end p 7
###begin p 8
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> Pax6</italic>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c28">28</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c30">30</xref>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c31">31</xref>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
 Pax6 is referred to as a 'master control gene' of eye development regulating several crystallin genes (28-30). Prox1 is expressed in the mouse lens placode at E9.5, in the lens vesicle (E10.5), in the anterior, proliferating epithelium and in differentiating fibre cells (from E12 onward). In Prox1 knock-out mutants lens fibre cell elongation is affected and Crygd expression is decreased, whereas Cryge/f expression remains constant (31).
###end p 8
###begin p 9
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> Six3</italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c32">32</xref>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c33">33</xref>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 618 623 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 624 625 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 741 746 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 747 748 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 849 854 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 855 856 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 119 125 <span type="species:ncbi:8090">medaka</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
 Six3 is important for early eye development, as demonstrated recently by its ectopic expression in the ear placode of medaka fish. This ectopic expression leads to formation of a morphologically intact lens in the ear placode, including expression of crystallins (32). Moreover, Six3 was found to be expressed at E6.5 in the head fold, a region later forming the mouse eye anlagen; however, in the lens it was not detected after E18 (33). Therefore, we investigated the role of those three transcription factors in the regulation of Cryg gene expression in some detail. We could demonstrate that Prox1 stimulates the Cryge/f promoter approximately10-fold, but Six3 represses it to near background level. Pax6 is obviously without effect on Cryge/f expression. Based upon these data, we suggest an antagonistic model of Prox1 and Six3 action at the Cryge/f promoter.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Cell lines
###end title 11
###begin p 12
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c34">34</xref>
###xml 643 644 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 780 781 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 140 144 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Human lens epithelial cell line CD5A was established from epithelial cells of donor lenses. The cells were immortalised using adenovirus 12-SV40 hybrid virus, kindly provided by J. S. Rhim (Bethesda, MD) (34). Virus was produced in CV1 cells and stored at -80degreesC as culture supernatant. Virus was added directly to the lens epithelium upon arrival in the laboratory; the cells were monitored for growth over a 2-3 week period. Once the cells had migrated and covered >50% of the surface of a 24-well plate, they were trypsinised into a single well of a 6-well plate. These were allowed to grow to confluence and then passaged into a 25 cm2 flask. Cells were increased in number by passaging into larger flasks until ready for freezing down (typically passage 5) from a 175 cm2 flask.
###end p 12
###begin p 13
###xml 223 225 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c35">35</xref>
###xml 226 228 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c36">36</xref>
###xml 1 6 <span type="species:ncbi:10090">Mouse</span>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 176 182 <span type="species:ncbi:9986">rabbit</span>
 Mouse lens epithelial cell line alphaTN4 and mouse fibroblast-like cell line NIH 3T3 were cultured in DMEM under standard conditions; for the N/N1003A cell line EMEM with 10% rabbit serum was used as described previously (35,36).
###end p 13
###begin title 14
PCR and western blotting
###end title 14
###begin p 15
RNA was prepared from organs and cell lines using the RNAeasy system (Qiagen, Hilden, Germany). An aliquot of 5 microg total RNA was transcribed to first strand cDNA with a Ready To Gotrade mark T-primed First Strand Kit (Pharmacia Biotech, Freiburg, Germany).
###end p 15
###begin p 16
###xml 215 217 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c37">37</xref>
 PCR conditions using a Robocycler (Stratagene, Amsterdam, The Netherlands) for 15-40 cycles of denaturation at 95degreesC, with annealing and extension at 72degreesC, each for 45 s, have been previously described (37). PCR products were resolved on 3-5% agarose gels.
###end p 16
###begin p 17
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 57 63 <span type="species:ncbi:10090">murine</span>
###xml 297 302 <span type="species:ncbi:10090">mouse</span>
###xml 307 312 <span type="species:ncbi:9606">human</span>
 A 70 bp fragment of the 3'-untranslated region (UTR) of murine Six3 cDNA was amplified from the first strand cDNA and Six3-pcDNA3.1 using the primer pair 5'-AGAACAAACCGAAATCAGGATAC-3' and 5'-CACACTCCCACCCCAGCCAA-3'; the annealing temperature was 51degreesC. Primer binding sites are conserved in mouse and human. PCR products were sequenced directly. Furthermore, aliquots of RNA of the cells and organs were subjected to similar PCR reactions. No 70 bp fragment was amplified. Therefore, genomic contamination of the RNA preparations can be excluded.
###end p 17
###begin p 18
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PROX1</italic>
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c38">38</xref>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
 A 108 bp fragment encompassing parts of exons IV and V of the human PROX1 gene (38) was amplified from first strand cDNA and Prox1-pcDNA3 using the primer pair 5'-AATGACTTTGAGGTTCCAGAGAGATTCCTG-3' and 5'-CAAAGATGTTGATCCTTCCTGGAAGAAG-3', a conserved sequence in mouse and human; annealing was at 52degreesC.
###end p 18
###begin p 19
###xml 386 388 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c39">39</xref>
###xml 627 628 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 644 645 640 641 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 647 648 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 746 747 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 782 783 766 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 784 785 768 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 413 417 <span type="species:ncbi:9925">goat</span>
###xml 423 429 <span type="species:ncbi:9986">rabbit</span>
 For western blot analysis 10 microg of each cell preparation was electrophoresed through a SDS-7% polyacrylamide gel and electroblotted onto a PVDF membrane. The membrane was blocked overnight in 5% powdered milk in phosphate-buffered saline and incubated with a 1:1000 dilution of an antibody raised against the homeodomain and C-terminal domain (amino acids 546-736) of human PROX1 (39). Peroxidase-conjugated goat anti-rabbit IgG (Dianova, Hamburg, Germany) was used at 1:10 000 in TBST (10 mM Tris, pH 8.0, 150 mM NaCl, 0.05% Tween-20). Peroxidase was detected by incubation for 15 min in a 15 ml volume comprising 10 ml H2O, 5 ml 50 mM Na3PO4, pH 7.5, 750 mM NaCl, 500 mM imidazole, 0.25% Tween-20 and 5 mg diaminobenzidine, 100 microl CoCl2 (40 microg/ml) and 10 microl 30% H2O2.
###end p 19
###begin title 20
Reporter plasmids and expression systems
###end title 20
###begin p 21
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c40">40</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c41">41</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c42">42</xref>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 364 366 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c15">15</xref>
###xml 417 419 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c43">43</xref>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 501 505 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
5'-Deletions of the Cryge promoter (40) were cloned into the reporter gene vector pBLCAT6 (41) or its derivative pEK0CAT (42). The resulting constructs represented fragments (-629/+37), (-514/+37), (-325/+37), (-219/+37), (-163/+37), (-124/+37), (-77/+37), (-25/+37) and (-629/+8) of the Cryge promoter. The mouse (-226/+45) Crygf promoter plasmid pgamma226LucII (15) as well as the promoter-less construct pPLLucII (43) were kindly provided by Y. Kamachi (Nagoya, Japan). Control reporter vector pRL-SV40 was purchased from Promega (Heidelberg, Germany).
###end p 21
###begin p 22
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dra</italic>
 Pax6 cDNA subcloned in the pBluescriptKS(+) vector was kindly provided by R. Balling (Neuherberg, Germany). After digestion with BamHI and DraI it was subcloned into the eukaryotic expression vector pSG5 (Stratagene, Heidelberg, Germany); the resulting plasmid is referred to as pSG-Pax6.
###end p 22
###begin p 23
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
 For expression of Six3, the EcoRI fragment of plasmid pC5Six3 containing the full-length Six3 cDNA (kindly provided by P. Gruss, Gottingen, Germany) was subcloned into the pcDNA3.1 expression vector. The complete Prox1 coding sequence was cloned into the pcDNA3 expression vector (Invitrogen).
###end p 23
###begin p 24
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 121 124 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 194 196 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
 The generated plasmids, Prox1-pcDNA3 and Six3-pcDNA3.1, were expressed in vitro using the reticulocyte lysate of the TNT(R) Quick Coupled Transcription/Translation System (Promega) containing [35S]methionine. An aliquot of 1 microl of lysate was electrophoresed through a 7% SDS-polyacrylamide gel, the gel was dried under vacuum and radioactivity was detected overnight on a Fuji Imaging Plate using a PhosphorImager SI (Amersham Pharmacia Biotech).
###end p 24
###begin p 25
 Eukaryotic cell lines N/N1003A and CD5A were also used to express Pax6, PROX1 and Six3.
###end p 25
###begin title 26
Random mutagenesis of the gammaF-crystallin core promoter
###end title 26
###begin p 27
###xml 203 209 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 211 213 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c44">44</xref>
###xml 308 311 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 425 428 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 494 496 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c44">44</xref>
###xml 507 508 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 656 658 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c43">43</xref>
###xml 670 673 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 680 683 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
To detect regions of functional interest, mutations were randomly introduced into the gammaF-crystallin promoter between positions -214 and +48 using the PCR random mutagenesis protocol according to Wan et al. (44). The forward PCR primer (5'-CAC CTG GAT CCT CTA CAG TCG AGG CCC AAG CTA CAT C-3') contains a BamHI site for cloning, whereas the reverse PCR primer (5'-GAG GCC AAG CTT CGC TGG TGT TGG CAG GTC AGA TGG-3') has a HindIII restriction site. The PCR buffers were exactly as described (44); the MnSO4 concentrations used were 0.1, 0.2 and 0.8 mM for clones 1-15, 16-36 and 37-40 respectively. The PCR products were cloned into the pPLLucII vector (43) using the BamHI and HindIII restriction sites and transfected into DH5alpha bacteria. Forty clones (out of 96) had an insert and have been characterised by sequencing in both directions using an ABI-3100 sequencer (PE Biosystems, Weiterstadt, Germany); the forward primer was 5'-AAG CTT CGC TGG TGT TGG-3' and the reverse primer 5'-GGA TCC TCT AGA GTC GAG GC-3'; DNA was prepared using a plasmid NucleoSpin column (Macherey Nagel, Duren, Germany).
###end p 27
###begin title 28
Transfection and reporter gene assay
###end title 28
###begin p 29
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
For chloramphenicol acetyltransferase (CAT) reporter gene assays, 7 x 105 cells per 35 mm diameter dish were seeded. Twenty-four hours later cells were transfected with 3 or 4 microg plasmid DNA plus 0.2 microg pCMVbeta (Clontech, Heidelberg, Germany) using LipofectAMINE (Gibco, Eggenstein, Germany) or DOSPER (Roche, Mannheim, Germany). Seventy-two hours after transfection cells were harvested and 100 microg cell extract was assayed for CAT using a CAT-ELISA kit (Roche). Additionally, 10 microg were assayed for beta-galactosidase activity for internal standardisation.
###end p 29
###begin p 30
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 245 249 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 For luciferase (Luc) reporter gene assays 1.5 x 105 cells were cultivated in 12-well plates for 24 h and transfected by the calcium phosphate precipitation method. Each dish received 2 microg pgamma226LucII reporter plasmid and 0.02 microg pRL-SV40 control plasmid and various amounts of the Six3-pcDNA3.1 or Prox1-pcDNA3 expression plasmid, respectively, or the parental plasmid pcDNA3.1.
###end p 30
###begin p 31
###xml 275 279 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 For analysis of the randomly mutated core promoter fragments, calcium phosphate transfection into the CD5A cell line was performed using 2 microg mutated promoter fused to the Luc reporter gene, 0.4 microg effector (either Prox1-pcDNA3 or Six3-pcDNA3.1) and 0.02 microg pRL-SV40 for transfection control.
###end p 31
###begin p 32
 Cells were harvested 48 h after transfection and cellular extracts were prepared by multiple freeze/thaw cycles. The extracts were assayed in triplicate with the Dual-Luciferase Reporter Assay System (Promega) and the standard deviations calculated.
###end p 32
###begin title 33
DNA interaction
###end title 33
###begin p 34
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 481 483 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 765 770 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 680 686 <span type="species:ncbi:9913">bovine</span>
For affinity binding and precipitation, fragments (-226/+46, -214/-165, -164/+115, -114/-65, -64/-15, -14/+36, -184/-145, -134/-95, -84/-45 and -34/+6) of the Crygf promoter were Biotin-16-ddUTP (Roche) end-labelled and immobilised on uniform, paramagnetic polystyrene beads via Streptavidin covalently attached to the bead surface (Deutsche Dynal, Hamburg, Germany). An aliquot of 0.5 microg immobilised DNA sequence was incubated with 1 microl of reticulocyte lysate containing [35S]methionine-labelled Six3 in 20 microl of binding buffer (50 mM Tris-HCl, pH 7.9, 0.1 mM EDTA, 0.01% NP13 detergent, 1 mM DTT, 10% glycerol, 70 mM NaCl) containing 250 ng poly(dI.dC) and 3 microg bovine serum albumin. In preliminary experiments Six3 did not bind to the (-114/-65) Crygf promoter fragment. Therefore, we added a 50-fold molar excess of non-immobilised (-114/-65) fragment as non-specific competitor. Binding was for 20 min at 30degreesC. Pellets were washed four times in binding buffer containing an additional 200 mM KCl and electrophoresed on SDS-polyacrylamide gels according to standard procedures.
###end p 34
###begin p 35
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 535 540 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 739 744 739 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
 In control experiments binding and washing were carried out as described above using the immobilised (-226/+45) Crygf promoter fragment. We eluted with a 50-fold molar excess of non-immobilised Crygf fragments, to displace Six3 from the (-226/+45) Crygf promoter. In particular, Six3 specifically binds to the (-226/+45) Crygf promoter fragment and also to those Crygf fragments that contain a specific Six3-binding site. Because of the excess of specific competitor Crygf fragments, Six3 is displaced from the immobilised (-226/+45) Crygf promoter and is eluted in the supernatant. In contrast, an excess of non-specific Crygf fragments do not compete with the (-226/+45) Crygf promoter. Six3 remains bound on the immobilised (-226/+45) Crygf promoter and stays in the pellet. Supernatant and pellet were electrophoresed on SDS-polyacrylamide gels according to standard procedures.
###end p 35
###begin title 36
RESULTS
###end title 36
###begin title 37
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
Comparison of several Crygd/e/f promoters: prediction of novel transcription factor-binding sites
###end title 37
###begin p 38
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c45">45</xref>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f1">1</xref>
###xml 244 249 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGF</italic>
###xml 288 290 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c24">24</xref>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 34 37 <span type="species:ncbi:10116">rat</span>
###xml 42 45 <span type="species:ncbi:9606">man</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
The Crygd/e/f promoters of mouse, rat and man were analysed for transcription factor-binding sites using MatInspector Professional (45). The alignments and the common binding sites are summarised in Figure 1. Since the promoter of the human psiCRYGF gene lacks typical promoter features (24), it was not included in this comparison.
###end p 38
###begin p 39
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 204 209 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGD</italic>
###xml 217 222 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGE</italic>
###xml 231 236 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 424 429 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 430 431 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 432 433 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 227 230 <span type="species:ncbi:10116">rat</span>
 The analysed Crygd/e/f promoters show high homology, especially in the proximal region, implicating various common promoter elements. All of them contain a Sox1- and a gammaFBP-binding site. Since human CRYGD and psiCRYGE and rat Crygd do not contain the Silencer and Cryner elements, as well as the RARE element, it is concluded that these particular promoters could be different to the others. These rodent promoters for Crygd/e/f were defined as a separate subfamily.
###end p 39
###begin p 40
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
 Some 35 additional transcription factor-binding sites were identified using MatInspector Professional (). All were conserved in positions for proximal promoters of the rodent Crygd/e/f subfamily. Of these, seven were binding sites for proteins containing a homeodomain or a paired domain and are located in the region -211 to -105. These included Pax6- and Prox1-binding sites. Pax6 and PROX1 are important for lens development and fibre cell differentiation and so provided the focus for the present studies.
###end p 40
###begin p 41
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGD</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 194 199 <span type="species:ncbi:9606">human</span>
 The region -198 to -186 is predicted as a binding site for the paired domain of Pax6; it partly overlaps with the retinoic acid response element (RARE). A similar module is also present in the human CRYGD promoter, but at a more upstream position. In fact, all distal Crygd/e/f promoters have predicted Pax6-binding sites, but at different positions.
###end p 41
###begin p 42
###xml 68 78 68 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c46">46</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c47">47</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c31">31</xref>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryd</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 68 78 <span type="species:ncbi:7227">Drosophila</span>
 The region -125 to - 131 contains a predicted binding site for the Drosophila protein Prospero (46). Prospero is closely related to the vertebrate homologue Prox1 (47), which is required for lens fibre cell elongation (31), suggesting that PROX1 could be important for Cryd/e/f core promoter activity.
###end p 42
###begin p 43
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c33">33</xref>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 477 478 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
 It is the combination of transcription factors that is important for lens development and other initial analyses of the core promoter have identified a large number of putative sites for transcription factors. To positively identify other transcription factors involved in regulating the Crygd/e/f core promoter, we chose to study the effect of Six3 because of the recent demonstration of its importance in eye development (33). Our experimental approach was to monitor Crygd/e/f promoter activity after overexpression of Pax6, Prox1 and Six3 in lens epithelial cell lines.
###end p 43
###begin title 44
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
Characterisation of the rodent Crygd/e/f promoter
###end title 44
###begin p 45
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f2">2</xref>
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAT</italic>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc</italic>
###xml 363 368 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 829 834 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 882 887 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 888 889 880 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 890 891 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 908 909 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f2">2</xref>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
As examples for the Crygd/e/f promoters we used several deletion constructs of either the mouse Cryge or Crygf promoter (Fig. 2a) driving the CAT or Luc gene as reporter. These were transfected into lens epithelial cell lines N/N1003A, alphaTN4 and CD5A; non-lens derived NIH 3T3 cells were used as a control. In N/N1003A and alphaTN4 cells the entire (-629/+37) Cryge promoter shows 4-5 times higher activity than the promoter-less reporter vector. Deletion of the fragment -629 to -219 results in an additional 2.5-fold increase in promoter activity; fragment (-219/+37) is the most active and further deletions produced fragments not significantly different in activity from the promoter-less reporter vector. The only exception is the (-77/+37) fragment, which has 2.6-fold the background activity. Therefore, the (-219/+37) Cryge element is defined as the core promoter of the Crygd/e/f subfamily (Fig. 2b).
###end p 45
###begin p 46
###xml 211 216 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 297 302 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 62 68 <span type="species:ncbi:9986">rabbit</span>
###xml 107 113 <span type="species:ncbi:10090">murine</span>
###xml 315 321 <span type="species:ncbi:9986">rabbit</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
 A better response for the basal promoter was obtained in the rabbit cell line N/N1003A as compared to the murine cell line alphaTN4. This was selected for our detailed studies. In line with the features of the Cryge promoter, a 10-fold elevation of basal activity was observed for the (-226/+45) Crygf promoter in rabbit N/N1003A cells and also in human CD5A cells. Activation of the promoter fragment was lens cell specific, as no activity was detected in the fibroblast cell line NIH 3T3.
###end p 46
###begin title 47
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
Influence of Pax6 on the Cryge promoter
###end title 47
###begin p 48
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c42">42</xref>
###xml 125 131 <span type="species:ncbi:9986">rabbit</span>
We investigated the ability of Pax6 to stimulate the entire Cryge promoter by co-transfection of increasing amounts into the rabbit N/N1003A cell line. No statistically significant difference was observed between cells co-transfected or not with the Pax6 expression plasmid (data not shown). Since Pax6 was shown (42) to be expressed in all cell lines derived from the lens (N/N1003A, alphaTN4 and NKR) or of neuronal origin (PC12, U87 and U373), exogenous addition of Pax6 might not influence the endogenous effect.
###end p 48
###begin title 49
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
Function of Prox1 at the Crygf promoter
###end title 49
###begin p 50
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f3">3</xref>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f3">3</xref>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1 </italic>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f3">3</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f3">3</xref>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
Endogenous expression of Prox1 in the cell lines used was analysed by western blotting. A band of the expected size (90 kDa) was detected in N/N1003A, but not in CD5A, cells (Fig. 3a). We confirmed these results by RT-PCR; Prox1 is expressed in N/N1003A cells, but not in CD5A cells (Fig. 3b). To obtain Prox1 protein for further investigations, Prox1 cDNA was cloned in the expression vector pcDNA3. The PROX1-pcDNA3 plasmid was transcribed and translated in reticulocyte lysate (Fig. 3c). PROX1 protein was detected in transfected CD5A cells (Fig. 3a). Therefore, we used the CD5A cell line (which does not express endogenous Prox1) to test the effect of Prox1 on the Crygf promoter.
###end p 50
###begin p 51
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 218 223 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 360 365 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 385 386 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f4">4</xref>
###xml 593 598 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 618 623 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
 In transient co-transfection experiments we investigated the ability of Prox1 to regulate the Crygf promoter. Therefore, increasing amounts of Prox1-pcDNA3 were co-transfected with pgamma226LucII. Prox1 activates the Crygf promoter 10-fold with a sigmoid dose-response curve; to avoid an overloading effect of the transfection system, no more than 0.4 microg Prox1 DNA was used (Fig. 4). In contrast to CD5A cells, only a 2-fold activation of the promoter without a clear dose-dependent relationship was observed in N/N1003A cells. This difference might be caused by endogenous expression of Prox1 in N/N1003A cells. Prox1 did not affect pPLLucII, indicating promoter-specific effects.
###end p 51
###begin p 52
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f5">5</xref>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c9">9</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c10">10</xref>
 To test whether the predicted Prospero-binding site is responsible for stimulation of the Crygf promoter, we used a set of 36 mutated promoter fragments. The mutations were randomly distributed within the entire proximal core promoter fragment (-214/+48). As demonstrated in Figure 5, clones 7, 15, 19, 36 and 38 lost their ability to stimulate the Crygf promoter. The observed reporter gene activity corresponds to the control level without Prox1 stimulation. Four of these mutations were localised within an interval between -151 and -174. Clone 15 affects the RARE element, which was demonstrated previously to be important for Crygf expression (9,10). Some other mutations found within this region obviously do not influence Prox1-dependent promoter activity (clones 13, 14, 17 and 29).
###end p 52
###begin p 53
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c12">12</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c13">13</xref>
 Clones 30 and 31 additionally enhance the stimulatory activity of Prox1 3-fold (i.e. 30-fold over the control). Mutation 31 is very close to the inhibitory mutation 19, but another mutation two bases downstream is without effect on Prox1 stimulation (clone 4). Therefore, all five of these mutations (7, 19, 31, 36 and 38) define a Prox1-responsive element (PRORE) between positions -151 and -174. The other mutation enhancing the Prox1 stimulatory effect (clone 30) is localised at position -68 within the silencer element (12,13); it is suggested that destruction of the silencer enhances the possibility of Prox1 stimulating the promoter.
###end p 53
###begin title 54
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
Function of Six3 at the Crygf promoter
###end title 54
###begin p 55
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c33">33</xref>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f6">6</xref>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 308 314 <span type="species:ncbi:9986">rabbit</span>
###xml 397 403 <span type="species:ncbi:9986">rabbit</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
###xml 461 464 <span type="species:ncbi:9606">man</span>
We confirmed Six3 expression in the mouse eye at E12.5 as reported previously (33) by RT-PCR. Endogenous transcription of Six3 was also detected in human CD5A lens epithelial cell lines. The detection limit of PCR for Six3 is approximately 1000 molecules of Six3-pcDNA3.1 per reaction (Fig. 6). Six3 cDNA in rabbit N/N1003A cells could not be amplified, because the corresponding sequences of the rabbit are not yet known and conserved sequences from mouse and man could not be used successfully.
###end p 55
###begin p 56
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 243 247 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 297 302 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 362 366 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 395 399 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 449 454 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 470 471 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f7">7</xref>
###xml 489 493 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 582 587 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 661 662 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f7">7</xref>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 195 201 <span type="species:ncbi:9986">rabbit</span>
 As described for Prox1, we investigated the influence of Six3 on Crygf expression. Increasing amounts of Six3-pcDNA3.1 were co-transfected with pgamma226LucII into human CD5A lens epithelial or rabbit N/N1003A cells. As little as 6 ng of the Six3 expression plasmid repressed the activity of the Crygf promoter by 40%, compared to the promoter activity without Six3-pcDNA3.1. Larger amounts of Six3 expression vector led to total repression of the Crygf promoter (Fig. 7a). As a control, Six3 shows no effect on the promoter-less pPLLucII reporter plasmid. A similar repression of Crygf promoter activity was also observed after its stimulation by Prox1 (Fig. 7b).
###end p 56
###begin p 57
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f8">8</xref>
 To obtain Six3 protein in sufficient amounts for further investigations, Six3 cDNA was cloned into the expression vector pcDNA3.1. The corresponding Six3-pcDNA3.1 plasmid was transcribed and translated in reticulocyte lysate. Using SDS-PAGE, the expected 37 kDa size for full-length Six3 is observed (Fig. 8a).
###end p 57
###begin p 58
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f8">8</xref>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 501 506 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f8">8</xref>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 826 831 826 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
 We investigated the ability of Six3 to interact with the Crygf core promoter by DNA precipitation. In vitro expressed Six3 was precipitated by immobilised DNA fragments (-184/-145) and (-164/-115) of the Crygf promoter (Fig. 8b, lane 1). To confirm the specificity of the interaction, oligonucleotides derived from the core promoter were used to compete off Six3 bound to the (-226/+45) Crygf promoter. Only oligonucleotides representing the sequences (-214/-165), (-184/-145) and (-164/-115) of the Crygf promoter were able to displace Six3 (Fig. 8b, lanes 2 and 3). Obviously, Six3 can be displaced from the Crygf promoter by the sequence -184/-145, but it does not bind to it. This might be caused by steric inhibition due to biotin-Streptavidin-mediated binding of the oligonucleotide to the matrix. All fragments of the Crygf promoter downstream of base pair -115 did not show any specific interaction with Six3.
###end p 58
###begin p 59
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f9">9</xref>
 To decide whether in vitro binding to the overlapping promoter fragments has functional relevance, the same 36 clones as used for definition of the PRORE were used for transient transfections with Six3. Loss of the inhibitory action of Six3 was used to demonstrate an important function of the corresponding bases. As outlined in Figure 9, two clones (9 and 37) led to a complete loss of Six3 repressor activity. Both clones have mutations in the interval between -121 and -117. Moreover, six other clones (1-3, 12, 30 and 38) show only about half of the Six3 repressor activity of the wild-type promoter. The corresponding positions were all between -101 and -123 except for clone 2, which obviously destroys the Sox1-binding site. Since all other clones do not demonstrate an effect on Six3 repressor activity, the Six3-responsive element (SIRE) can be defined as between positions -101 and -123.
###end p 59
###begin title 60
DISCUSSION
###end title 60
###begin title 61
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 35 36 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
Similar regulation of rodent Crygd/e/f genes
###end title 61
###begin p 62
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c10">10</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c40">40</xref>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f1">1</xref>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c48">48</xref>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c9">9</xref>
###xml 806 811 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 830 831 823 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c9">9</xref>
###xml 844 848 837 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 937 942 930 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 953 955 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c15">15</xref>
###xml 956 958 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c49">49</xref>
###xml 994 996 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c47">47</xref>
###xml 1063 1065 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c16">16</xref>
###xml 1068 1073 1057 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Maf</italic>
###xml 1106 1110 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 1118 1120 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c50">50</xref>
###xml 1252 1254 1233 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c17">17</xref>
###xml 1286 1289 1263 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FBP</italic>
###xml 1291 1295 1268 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hic1</italic>
###xml 1365 1367 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c51">51</xref>
###xml 23 26 <span type="species:ncbi:10116">rat</span>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 38 41 <span type="species:ncbi:9606">man</span>
###xml 345 351 <span type="species:ncbi:9986">rabbit</span>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
###xml 1136 1143 <span type="species:ncbi:9031">chicken</span>
###xml 1261 1266 <span type="species:ncbi:10090">mouse</span>
The Crygd/e/f genes of rat, mouse and man are highly conserved (10,40). A corresponding level of conservation is also found for their proximal promoters (Fig. 1), indicating a similar regulation of this gene subfamily. In line with their homology, the Cryge and Crygf promoters show similar activities in corresponding deletion constructs using rabbit N/N1003A cells as hosts. Successive deletion of the distal part of the Cryge promoter from base pair -629 to -219 leads to an increase in promoter activity, as observed for the Crygf promoter (48). Promoter fragments missing the sequences upstream of position -219 have lost most of their activity because of the deleted RARE element (9). Mediated by this element, co-transfection with recombinant RARalpha and RARbeta receptors enhanced activity of the Crygf promoter 25-fold (9). Moreover, Cryg genes are activated by Sox1 and Maf via corresponding promoter elements in the proximal Crygf promoter (15,49). The L-Maf-binding element (MARE; 47) is nearly identical to the previously reported gammaF-1 element (16); c-Maf null mutant mice do not express Cryg genes (50). However, the chicken gammaFBP protein (binding to the gammaF-1-binding site) inhibits promoter activity in reporter gene assays (17). The mouse orthologue of gammaFBP, Hic1, is expressed in a variety of embryonic tissues, but not in the eye (51).
###end p 62
###begin p 63
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> Pax6</italic>
###xml 125 135 125 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c52">52</xref>
###xml 170 179 170 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Small eye</italic>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c53">53</xref>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 354 355 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c45">45</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c28">28</xref>
###xml 846 850 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 933 938 929 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 939 940 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 125 135 <span type="species:ncbi:7227">Drosophila</span>
 Pax6 is considered one of the most important genes in lens development because of its induction of ectopic eye formation in Drosophila (52) and because of the series of Small eye mutations, which do not develop eyes at all in the homozygous condition (53). In contrast to former observations (55), we detected a potential Pax6-binding site in the Crygd/e/f promoters using the computer program MatInspector Professional (45) for promoter analysis. However, from our co-transfection experiments no indication of either an activating or an inhibitory influence of Pax6 can be deduced. Even if N/N1003A cells express endogenous Pax6, a small stimulatory effect should be expected, as seen for PROX1. Moreover, in the same cell line Cvekl and colleagues (28) demonstrated that the alphaA-crystallin promoter could be stimulated by overexpression of Pax6. Therefore, we conclude that the predicted binding site is not active in the core Cryge/f promoter.
###end p 63
###begin title 64
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 35 36 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
Prox1 is an activator of the Crygd/e/f genes
###end title 64
###begin p 65
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c45">45</xref>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c31">31</xref>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 676 681 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 237 242 <span type="species:ncbi:10090">mouse</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
Using the MatInspector program (45), we found a Prospero-binding site in all Crygd/e/f promoters. The homologous gene in mammals, Prox1, seems to be very important for lens development and differentiation, because it is expressed in the mouse lens from the placode stage onward. Moreover, in Prox1-/- mice lens fiber cell elongation is affected (31). Our cell culture data using the CD5A lens epithelium cell line strongly support the idea that Prox1 is an important activator of Cryg expression. However, our random mutagenesis screen for promoter activity demonstrates that the predicted Prospero-binding site (-125/-131) is not responsible for the function of Prox1 at the Crygf promoter. A mutation within this region does not change the stimulatory activity of Prox1, whereas mutations in a more upstream region between positions -151 and -174 lead to either a complete loss of the stimulatory activity or to a significant increase. Therefore, we have defined this region as the Prox1-responsive element (PRORE).
###end p 65
###begin p 66
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 371 376 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 420 425 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 425 428 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 441 446 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 446 449 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 465 470 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 483 488 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 489 490 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 559 564 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prox1</italic>
###xml 564 567 562 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;/&#8211;</sup>
###xml 592 594 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c31">31</xref>
###xml 647 652 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 657 662 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
###xml 155 158 <span type="species:ncbi:10116">rat</span>
###xml 251 254 <span type="species:ncbi:10116">rat</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
 All mutations affecting stimulation of the Crygf promoter by PROX1 are conserved in the Crygd/e/f promoters of the mouse and the Cryge/f promoters of the rat. The only exception is clone 31, which has a G instead of an A in the Crygd promoter of the rat. This position, being responsible for higher stimulation by PROX1 in clone 31 (A-->T), might also have an effect on Crygd expression, which could not be observed in Prox1-/- mice. These Prox1-/- mice lost only Crygd expression; Cryge/f expression was observed. Even if no quantitative expression data in Prox1-/- mice are yet available (31), additional activators are obviously important for Cryge and Crygf expression.
###end p 66
###begin title 67
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
Six3 represses Crygd/e/f gene expression
###end title 67
###begin p 68
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 366 368 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c33">33</xref>
###xml 384 388 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 440 444 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 507 509 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f10">10</xref>
The data presented here demonstrate a function of Six3 interaction with the Crygf promoter resulting in a significant decrease as compared to its basal activity. Furthermore, Six3 is able to obliterate the activator PROX1. Six3 repression of the Crygf promoter explains the inversely related expression pattern of Six3 and gamma-crystallins during lens development (33). The start of Cryg expression correlates with decreased expression of Six3, which is not expressed in lens fibres later than E14.5 (Fig. 10).
###end p 68
###begin p 69
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c12">12</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke131c13">13</xref>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 714 715 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 716 717 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 755 756 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 802 810 802 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 974 981 974 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 735 740 <span type="species:ncbi:10090">mouse</span>
###xml 774 777 <span type="species:ncbi:10116">rat</span>
 An interesting question might be whether Six3 can be understood as the silencer interacting with the corresponding element defined by Peek et al. (12,13). However, our data do not support this hypothesis, since the silencer element is located between positions -76 and -58. Our DNA binding studies defined a Six3-binding region between -214 and -115. Using a random mutagenesis screen for the Crygf promoter, we could define a SIRE in the region between -101 and -123. In this region mutations in the Crygf promoter change the repressive effect of Six3 significantly; mutations outside obviously do not influence Six3 function on the Crygf promoter. All positions of the mutated clones are conserved in the Crygd/e/f promoters of the mouse and the Cryge/f promoters of the rat. The expanded region of in vitro DNA binding and the shorter region defined by the cell culture experiments might be explained by the assumption that these positions might not be accessible under in vivo conditions.
###end p 69
###begin p 70
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke131f11">11</xref>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
 Our current model of Cryg gene activation is summarised in Figure 11. Cryg genes are not expressed during early eye development and lens formation due to inhibition by Six3. As soon as Six3 disappears from the lens fibres, Cryg genes are switched on, activated by Prox1 (as well as by c-Maf and Sox1). The concerted actions of Prox1, c-Maf and Sox1 are enhanced when repression by Six3 is removed. In contrast, in lens epithelium Prox1 is expressed, however, no Cryg expression occurs. The reason for this is absence of the activators L/c-Maf and Sox1. Outside the eye lens c-Maf, Sox1 and Prox1 are not co-expressed, therefore no Cryg expression can be observed in other tissues.
###end p 70
###begin title 71
Figures and Tables
###end title 71
###begin p 72
###xml 5 10 5 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f </italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 533 534 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</italic>
###xml 1071 1076 1051 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 1095 1100 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 1121 1126 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 1147 1152 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 1171 1176 1151 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 1197 1202 1177 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGF</italic>
###xml 1223 1228 1203 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGD</italic>
###xml 1247 1252 1227 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 1273 1278 1253 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGE</italic>
###xml 1299 1304 1279 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGD</italic>
###xml 1312 1317 1290 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYGE</italic>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 165 168 <span type="species:ncbi:10116">rat</span>
###xml 240 245 <span type="species:ncbi:10090">mouse</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 1065 1070 <span type="species:ncbi:10090">mouse</span>
###xml 1091 1094 <span type="species:ncbi:10116">rat</span>
###xml 1115 1120 <span type="species:ncbi:10090">mouse</span>
###xml 1141 1146 <span type="species:ncbi:10090">mouse</span>
###xml 1167 1170 <span type="species:ncbi:10116">rat</span>
###xml 1191 1196 <span type="species:ncbi:9606">human</span>
###xml 1217 1222 <span type="species:ncbi:9606">human</span>
###xml 1243 1246 <span type="species:ncbi:10116">rat</span>
###xml 1267 1272 <span type="species:ncbi:9606">human</span>
###xml 1293 1298 <span type="species:ncbi:9606">human</span>
 The Crygd/e/f promoters of mammals. The mouse, rat and human Crygd/e/f promoters were compared by AlignX. Identical stretches are underlined in grey. The mouse and rat Crygd/e/f promoters are highly conserved between position -230 (of the mouse Crygf sequence) and the translational start site. It is commonly accepted that these sequences are necessary for lens-specific expression. The following sequence elements can be observed in all of them (positions refer to the mouse Crygf sequence): RARE, retinoic acid response element, -208/-183 (9,10); CRYNER, gamma-crystallin nested repeats, -87/-59 (11); SILENCER, -76/-58 (12,13); CRYGPEL, common gamma-crystallin promoter element, -67/-54 (14); SOX1, Sox1-binding site, -63/-44 (15); gammaF-1/gammaFBP, gammaF-crystallin binding protein, 46/-36 (16-18); TATA box, -23/-18; DOTIS, downstream of transcription initiation site, +15/+35 (19,20). Novel putative binding sites for Pax6 and Prospero predicted by MatInspector Professional are boxed in bold. The GenBank/EMBL accession nos of the aligned sequences are: mouse Crygf, M11039 (21); rat Crygf, M19357 (22); mouse Crygd, M16512 (23); mouse Cryge, X57855 (40); rat Cryge, M19359 (22); human CRYGF, K03009 (24); human CRYGD, K03005 (24); rat Crygd, M19359 (22), human CRYGE, K03007 (24); human CRYGD and psiCRYGE, AC018961 (25).
###end p 72
###begin p 73
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 35 36 35 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAT</italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Luc</italic>
###xml 420 421 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 450 455 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryge</italic>
###xml 611 614 595 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CAT</italic>
 Deletions at the Cryge promoter. (a) Deletion constructs. Schematic overview of the deletion constructs of the Cryge promoter cloned into the reporter gene CAT or Luc. Putative binding sites for Pax6 and Prospero are given in black. CCR is the gamma-crystallin common region (21), including the Cryner, Silencer, Crygpel and gammaF-1 elements as well as the Sox1- and gammaFBP-binding sites, as described in Figure 1. (b) Effects of deletion on the Cryge promoter. Transfection experiments were performed with N/N1003A or alphaTN4 lens epithelial cells or fibroblast-like NIH 3T3 cells. In all transfections a CAT construct was co-transfected with pCMVbeta vector for internal standarisation of efficiency of gene transfer. Cell extracts were measured for CAT expression by CAT ELISA and for beta-galactosidase activity. All data were normalised to the promoter-less plasmid, which was set as 1.
###end p 73
###begin p 74
###xml 23 24 23 24 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PROX1</italic>
###xml 472 473 472 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PROX1</italic>
###xml 739 740 739 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 742 750 742 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 853 855 853 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1026 1034 1026 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 283 288 <span type="species:ncbi:9606">human</span>
 Expression of PROX1. (a) Western blot analysis of PROX1 in N/N1003A and CD5A cells. Lysates of N/N1003A cells (lane 1), CD5A cells (lane 3) and PROX1-pcDNA3-transfected CD5A cells (lane 2) were immunostained with antibody raised against the C-terminal part (amino acids 546-736) of human Prox1. The correct 90 kDa band was recognised in N/N1003A cells and in transiently PROX1-pcDNA3-transfected CD5A cells. Untransfected CD5A cells show no endogenous PROX1 expression. (b) Endogenous expression of PROX1 in lens epithelial cells. A 108 bp fragment encoding parts of exon IV and exon V of PROX1 could be detected in N/N1003A cells, but not in the CD5A cell line. For comparison, increasing amounts of PROX1-pcDNA3 were used as template. (c) In vitro expression of PROX1. PROX1-pcDNA3 was transcribed and translated with reticulocyte lysate containing [35S]methionine. A 90 kDa band for PROX1 is apparent (lane 2). Shorter polypeptides are expressed when the second or third AUG was used as the initiation codon. As a control in vitro expression was performed with plasmid pcDNA3 without the cDNA sequence coding for PROX1 (lane 1).
###end p 74
###begin p 75
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 489 494 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
 PROX1 activates the Crygf promoter. Increasing amounts of PROX1 were co-transfected into CD5A and N/N1003A cells. Prox1 stimulates the Crygf promoter 2-fold in N/N1003A and 10-fold in CD5A cells as compared to its basal activity. To transfect a constant amount of DNA, the increasing amount of PROX1-pcDNA3 was compensated for by decreasing of the amount of empty vector pcDNA3. At the origin of the graph only pcDNA3 was used. In control experiments using a reporter plasmid without the Crygf promoter and with PROX1 overexpression in CD5A cells no alteration in relative luciferase activity was observed.
###end p 75
###begin p 76
 Altered Prox1 activation of mutated gammaF-crystallin promoters. The left control shows gammaF-crystallin promoter activity, which was co-transfected with the pcDNA3.1 expression vector not containing PROX1. In the right control, 29 of 36 point mutated gammaF-crystallin promoters are activated by PROX1, on average to 10-fold of their basal activities. On transfecting five of 36 mutated plasmids (7, 38, 29, 15 and 36) Prox1 produced no or reduced activation of the promoters as compared to their basal activity. In transfection experiments of two (30 and 31) of 36 mutated plasmids a 30-fold activation was observed. All mutations are represented in Figure 10.
###end p 76
###begin p 77
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
 Endogenous expression of Six3 in the mouse eye and human CD5A cell line. A 70 bp 3'-UTR was amplified from the CD5A cell line and the mouse eye at E12.5. For comparison, increasing amounts of Six3-pcDNA3.1 were used as template.
###end p 77
###begin p 78
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 37 38 37 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 460 465 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 579 580 575 576 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 811 816 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
 Six3 represses the Crygf promoter. (a) Increasing amounts of Six3 were co-transfected into CD5A and N/N1003A cells. Six3 represses the gammaF-cyrstallin promoter to <20% of its basal activity. To transfect a constant amount of DNA the increasing amount of Six3-pcDNA3.-1 was compensated for by decreasing the amount of the empty vector pcDNA3.-1. At the origin of the graph only pcDNA3.-1 was used. In control experiments using a reporter plasmid without the Crygf promoter and with Six3 overexpression in CD5A cells no alteration in relative luciferase activity was observed. (b) Constant amounts of the pgamma226LucII (2 microg) and PROX1-pcDNA3 (300 ng) plasmids were co-transfected into N/N1003A cells together with different amounts of Six3-pcDNA3.1 (0-90 ng). 100% is the basal activity of the untreated Crygf promoter. Six3 is able to obliterate Prox1 activation.
###end p 78
###begin p 79
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 44 45 44 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six3</italic>
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 249 257 249 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 362 363 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygf</italic>
 Six3 interaction with Crygf promoter DNA. (a) In vitro expression of Six3. Six3-pcDNA3.1 was transcribed and translated with reticulocyte lysate containing [35S]methionine. The correct 37 kDa band for Six3 is apparent (lanes 1 and 2). As a control in vitro expression was performed with the pcDNA3.1 plasmid without the cDNA sequence coding for Six3 (lane 4). (b) Affinity binding of Six3 to Crygf promoter sequences. The immobilised Crygf promoter sequences (-184-145) and (-164/-115) specifically precipitate Six3 (lane 1). As a control Six3 was bound to the immobilised (-226/+46) Crygf fragment. The free DNA sequences (-214/-165), (-184/-145) and (-164/-115) displace Six3 from the immobilised fraction (lane 2) into the supernatant (lane 3). Therefore, Six3 interacts with the Crygf promoter between nucleotides -214 and -115.
###end p 79
###begin p 80
 Reduced Six3 repression in mutated gammaF-crystallin promoters. The left control shows gammaF-crystallin promoter activity when co-transfected with the pcDNA3.1 expression vector not containing Six3. In the right control, 28 of 36 point mutated gammaF-crystallin promoters are repressed, on average to 20% of their basal activities, due to co-expression of Six3-pcDNA3.1. Transfecting eight of 36 mutated plasmids (12, 1, 30, 3, 2, 38, 37 and 9) Six3 produced diminished repression of the promoters to between 40 and 100% of their basal activities. All mutations are represented in Figure 10.
###end p 80
###begin p 81
###xml 431 439 427 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
 Alignment of mutated gammaF-crystallin promoters. For orientation, the transcription initiation site, the TATA box, the RARE, Silencer and Sox1 elements and the Prospero site are boxed. Point mutations are highlighted in grey. Point mutations affecting PROX1 activation (Fig. 5) or Six3 repression (Fig. 9) are marked in black. The resulting PRORE and SIRE are boxed in grey. Brackets show sequences which were shown to bind Six3 in vitro (Fig. 8b).
###end p 81
###begin p 82
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 401 406 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crygd</italic>
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 409 410 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryg</italic>
 Model of Crygd/e/f regulation during lens development. The retinoic acid receptors (interacting with the RARE element), Prox1 and Sox1 are activators, while Pax6 and Six3 are inhibitors of the Crygd/e/f promoters. The retinoic acid receptors, Pax6 (E8.0) and Six3 (E6.5) are expressed before eye development. Prox1 (E9.5, interacting with the PRORE element) is apparent even before lens development. Crygd/e/f are not expressed during early lens development due to the repressor Six3 (interacting with the SIRE). During lens fibre cell differentiation an additional activator, Sox1, is expressed. The repressor Six3 disappears. Therefore, Cryg expression begins in the fibre cells. In lens epithelium cells gamma-crystallins cannot be observed during lens development because of the presence of Six3 (until E18.0).
###end p 82
###begin title 83
ACKNOWLEDGEMENTS
###end title 83
###begin p 84
We gratefully acknowledge the receipt of clones and cell lines from R. Balling (Neuherberg, Germany), P. Gruss (Gottingen, Germany), Y. Kamachi (Nagoya, Japan), J. Reddan (Oakland, CA), J.S. Rhim (Bethesda, MD) and P. Russell (Bethesda, MD). Oligonucleotides were synthesised by Utz Linzner (GSF-AG BIODV). This work was supported, at least in part, by an ARC project grant (1061) from the British Council to R.A.Q. and a grant from the German Academic Exchange Service (DAAD) to J.G. (313-ARC-X).
###end p 84

